Purpose: This is the third paper in a series that reviews strategies for optimizing the validity and utility of randomized clinical trials (RCTs) in addictions treatment research. Whereas the two previous papers focused on design and implementation, here we address issues pertaining to data processing and statistical analysis. Scope: Recommendations for enhancing data quality and utility are offered in sections on data coding and entry; and data format, structure and management. We discuss the need for preliminary data analyses that examine statistical power; patterns of attrition; between‐group equivalence; and treatment integrity and discriminability. We discuss tests of treatment efficacy, as well as ancillary analyses aimed at explicati...
Randomized controlled trials (RCTs) provide the strongest evidence for the efficacy of preventive an...
This thesis presents a book and a collection of published papers concerned with statistical aspects ...
With the increasing number and variety of clinical trials and observational data analyses, producers...
Purpose: This is the third paper in a series that reviews strategies for optimizing the validity and...
Purpose: This paper is the first in a series that examines methods for improving the validity and ut...
Purpose: This paper is the second in a series that describes strategies for optimizing the validity ...
AbstractThis paper is a practical guide to the essentials of statistical analysis and reporting of r...
This paper is a practical guide to the essentials of statistical analysis and reporting of randomize...
Before a newly developed treatment starts being used in practice it must pass through three clinical...
This paper is a practical guide to the essentials of statistical analysis and reporting of randomize...
This paper is a practical guide to the essentials of statistical analysis and reporting of randomize...
Thesis by publication.Bibliography: pages 161-169.1. Introduction -- 2. Meta-analysis of clinical tr...
Randomised controlled trials (RCT s) are gold standard in the evaluation of treatment efficacy in me...
textabstractBefore a drug is allowed into clinical practice, randomized clinical trial (RCT) have b...
ABSTRACTRandomised controlled trials (RCT s) are gold standard in the evaluation of treatment effica...
Randomized controlled trials (RCTs) provide the strongest evidence for the efficacy of preventive an...
This thesis presents a book and a collection of published papers concerned with statistical aspects ...
With the increasing number and variety of clinical trials and observational data analyses, producers...
Purpose: This is the third paper in a series that reviews strategies for optimizing the validity and...
Purpose: This paper is the first in a series that examines methods for improving the validity and ut...
Purpose: This paper is the second in a series that describes strategies for optimizing the validity ...
AbstractThis paper is a practical guide to the essentials of statistical analysis and reporting of r...
This paper is a practical guide to the essentials of statistical analysis and reporting of randomize...
Before a newly developed treatment starts being used in practice it must pass through three clinical...
This paper is a practical guide to the essentials of statistical analysis and reporting of randomize...
This paper is a practical guide to the essentials of statistical analysis and reporting of randomize...
Thesis by publication.Bibliography: pages 161-169.1. Introduction -- 2. Meta-analysis of clinical tr...
Randomised controlled trials (RCT s) are gold standard in the evaluation of treatment efficacy in me...
textabstractBefore a drug is allowed into clinical practice, randomized clinical trial (RCT) have b...
ABSTRACTRandomised controlled trials (RCT s) are gold standard in the evaluation of treatment effica...
Randomized controlled trials (RCTs) provide the strongest evidence for the efficacy of preventive an...
This thesis presents a book and a collection of published papers concerned with statistical aspects ...
With the increasing number and variety of clinical trials and observational data analyses, producers...